(S)-nicotine decreases expression ISO RGD:1319635 6480464 Nicotine results in decreased expression of MAPK11 mRNA CTD PMID:17135361 17beta-estradiol affects localization EXP 6480464 Estradiol affects the localization of MAPK11 protein modified form CTD PMID:24465521 17beta-estradiol multiple interactions ISO RGD:1319634 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of MAPK11 mRNA, IGF1R mutant form inhibits the reaction [Estradiol results in increased expression of MAPK11 mRNA] CTD PMID:23094148 , PMID:30165855 17beta-estradiol increases expression ISO RGD:1319634 6480464 Estradiol results in increased expression of MAPK11 mRNA CTD PMID:23094148 17beta-estradiol increases expression ISO RGD:1319635 6480464 Estradiol results in increased expression of MAPK11 mRNA CTD PMID:22314386 17beta-estradiol multiple interactions EXP 6480464 Estradiol inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] inhibits the reaction [MAPK11 protein binds to SOD2 protein]], Estradiol inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased activity of MAPK11 protein] CTD PMID:24465521 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1319634 6480464 Tetrachlorodibenzodioxin affects the expression of MAPK11 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAPK11 mRNA CTD PMID:22808131 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1319635 6480464 Tetrachlorodibenzodioxin affects the expression of MAPK11 mRNA CTD PMID:21570461 3,4-methylenedioxymethamphetamine affects expression ISO RGD:1319635 6480464 N-Methyl-3, 4-methylenedioxyamphetamine affects the expression of MAPK11 mRNA CTD PMID:26251327 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1319635 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of MAPK11 mRNA CTD PMID:18648102 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of MAPK11 mRNA CTD PMID:28959563 afimoxifene decreases response to substance ISO RGD:1319634 6480464 MAPK11 results in decreased susceptibility to afimoxifene CTD PMID:21233418 aflatoxin B1 increases expression ISO RGD:1319634 6480464 Aflatoxin B1 results in increased expression of MAPK11 mRNA CTD PMID:21641981 arsenous acid increases activity ISO RGD:1319634 6480464 Arsenic Trioxide results in increased activity of MAPK11 protein CTD PMID:12239215 arsenous acid multiple interactions ISO RGD:1319634 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MAPK11 protein] more ... CTD PMID:12239215 , PMID:26598702 benzo[b]fluoranthene increases expression ISO RGD:1319635 6480464 benzo(b)fluoranthene results in increased expression of MAPK11 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MAPK11 promoter CTD PMID:23359474 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MAPK11 promoter CTD PMID:23359474 bisphenol A increases expression ISO RGD:1319635 6480464 bisphenol A results in increased expression of MAPK11 mRNA CTD PMID:29165653 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of MAPK11 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MAPK11 mRNA CTD PMID:25181051 , PMID:30816183 butanal increases expression ISO RGD:1319634 6480464 butyraldehyde results in increased expression of MAPK11 mRNA CTD PMID:26079696 cadmium atom increases expression ISO RGD:1319634 6480464 Cadmium results in increased expression of MAPK11 mRNA CTD PMID:23369406 cadmium dichloride multiple interactions ISO RGD:1319634 6480464 Cadmium Chloride inhibits the reaction [SB 203580 results in decreased expression of MAPK11 mRNA] more ... CTD PMID:19757093 cadmium dichloride multiple interactions ISO RGD:1319635 6480464 MAPK11 mutant form inhibits the reaction [MAP2K4 mutant form inhibits the reaction [Cadmium Chloride results in increased expression of HSPA1A protein]], MAPK11 mutant form promotes the reaction [Cadmium Chloride results in increased expression of HSPA1A protein] CTD PMID:18348256 cadmium dichloride increases expression ISO RGD:1319635 6480464 Cadmium Chloride results in increased expression of MAPK11 mRNA CTD PMID:22314386 cadmium dichloride decreases expression ISO RGD:1319634 6480464 Cadmium Chloride results in decreased expression of MAPK11 mRNA CTD PMID:19757093 cadmium dichloride increases expression ISO RGD:1319634 6480464 Cadmium Chloride results in increased expression of MAPK11 protein CTD PMID:19757093 calcitriol increases expression ISO RGD:1319634 6480464 Calcitriol results in increased expression of MAPK11 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1319634 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of MAPK11 mRNA CTD PMID:21592394 carbon nanotube increases expression ISO RGD:1319635 6480464 Nanotubes, Carbon analog results in increased expression of MAPK11 mRNA, Nanotubes, Carbon results in increased expression of MAPK11 mRNA CTD PMID:25554681 cisplatin increases expression ISO RGD:1319634 6480464 Cisplatin results in increased expression of MAPK11 mRNA CTD PMID:27392435 , PMID:27594783 cisplatin multiple interactions ISO RGD:1319634 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of MAPK11 mRNA CTD PMID:27392435 cocaine decreases expression ISO RGD:1319635 6480464 Cocaine results in decreased expression of MAPK11 mRNA CTD PMID:18355967 cocaine multiple interactions ISO RGD:1319635 6480464 FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of MAPK11 mRNA] CTD PMID:18355967 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of MAPK11 mRNA CTD PMID:26033743 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of MAPK11 mRNA CTD PMID:26033743 cyclosporin A decreases methylation ISO RGD:1319634 6480464 Cyclosporine results in decreased methylation of MAPK11 promoter CTD PMID:27989131 diarsenic trioxide increases activity ISO RGD:1319634 6480464 Arsenic Trioxide results in increased activity of MAPK11 protein CTD PMID:12239215 diarsenic trioxide multiple interactions ISO RGD:1319634 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MAPK11 protein] more ... CTD PMID:12239215 , PMID:26598702 diazinon increases methylation ISO RGD:1319634 6480464 Diazinon results in increased methylation of MAPK11 gene CTD PMID:22964155 dibutyl phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MAPK11 promoter CTD PMID:23359474 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Oxygen] inhibits the reaction [MAPK11 protein binds to SOD2 protein] more ... CTD PMID:24465521 disodium selenite multiple interactions ISO RGD:1319635 6480464 Sodium Selenite inhibits the reaction [Buthionine Sulfoximine results in decreased expression of MAPK11 mRNA] CTD PMID:17989939 disodium selenite increases expression ISO RGD:1319635 6480464 Sodium Selenite results in increased expression of MAPK11 mRNA, Sodium Selenite results in increased expression of MAPK11 protein CTD PMID:19363675 disodium selenite decreases expression ISO RGD:1319635 6480464 Sodium Selenite results in decreased expression of MAPK11 mRNA CTD PMID:17989939 elemental selenium increases expression ISO RGD:1319634 6480464 Selenium results in increased expression of MAPK11 mRNA CTD PMID:19244175 ellagic acid increases expression ISO RGD:1319634 6480464 Ellagic Acid results in increased expression of MAPK11 mRNA CTD PMID:23811531 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MAPK11 mRNA CTD PMID:29391264 ethyl methanesulfonate increases expression ISO RGD:1319634 6480464 Ethyl Methanesulfonate results in increased expression of MAPK11 mRNA CTD PMID:23649840 flurbiprofen multiple interactions ISO RGD:1319634 6480464 MAPK11 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein] CTD PMID:18056468 genistein decreases phosphorylation ISO RGD:1319634 6480464 Genistein results in decreased phosphorylation of MAPK11 protein CTD PMID:19497411 hemin multiple interactions ISO RGD:1319634 6480464 Hemin inhibits the reaction [IL18 protein results in decreased expression of MAPK11 protein] CTD PMID:18215737 ibuprofen multiple interactions ISO RGD:1319634 6480464 MAPK11 protein promotes the reaction [Ibuprofen results in increased expression of NGFR protein] CTD PMID:18056468 lead diacetate increases expression ISO RGD:1319635 6480464 lead acetate results in increased expression of MAPK11 mRNA CTD PMID:21322097 lead diacetate affects expression EXP 6480464 lead acetate affects the expression of MAPK11 CTD PMID:24293362 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of MAPK11 mRNA CTD PMID:28801915 methamphetamine increases expression ISO RGD:1319635 6480464 Methamphetamine results in increased expression of MAPK11 mRNA CTD PMID:26307267 methotrexate increases expression ISO RGD:1319634 6480464 Methotrexate results in increased expression of MAPK11 mRNA CTD PMID:21678067 methyl methanesulfonate increases expression ISO RGD:1319634 6480464 Methyl Methanesulfonate results in increased expression of MAPK11 mRNA CTD PMID:23649840 microcystin-LR increases expression ISO RGD:1319635 6480464 cyanoginosin LR results in increased expression of MAPK11 mRNA, cyanoginosin LR results in increased expression of MAPK11 protein CTD PMID:25986756 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of MAPK11 mRNA CTD PMID:28801915 nicotine decreases expression ISO RGD:1319635 6480464 Nicotine results in decreased expression of MAPK11 mRNA CTD PMID:17135361 obeticholic acid decreases expression ISO RGD:1319634 6480464 obeticholic acid results in decreased expression of MAPK11 mRNA CTD PMID:27939613 paraquat multiple interactions EXP 6480464 [Paraquat results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK11 protein CTD PMID:24376630 pentanal increases expression ISO RGD:1319634 6480464 pentanal results in increased expression of MAPK11 mRNA CTD PMID:26079696 pyrazoles decreases activity ISO RGD:1319634 6480464 Pyrazoles analog results in decreased activity of MAPK11 protein CTD PMID:12534346 pyrimidines decreases activity ISO RGD:1319634 6480464 Pyrimidines analog results in decreased activity of MAPK11 protein CTD PMID:12534346 quercetin increases expression ISO RGD:1319634 6480464 Quercetin results in increased expression of MAPK11 mRNA CTD PMID:27514524 reactive oxygen species multiple interactions EXP 6480464 [Paraquat results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK11 protein CTD PMID:24376630 S-butyl-DL-homocysteine (S,R)-sulfoximine decreases expression ISO RGD:1319635 6480464 Buthionine Sulfoximine results in decreased expression of MAPK11 mRNA CTD PMID:17989939 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO RGD:1319635 6480464 Sodium Selenite inhibits the reaction [Buthionine Sulfoximine results in decreased expression of MAPK11 mRNA] CTD PMID:17989939 SB 203580 decreases activity ISO RGD:1319634 6480464 SB 203580 results in decreased activity of MAPK11 protein CTD PMID:10998351 SB 203580 decreases expression ISO RGD:1319634 6480464 SB 203580 results in decreased expression of MAPK11 mRNA CTD PMID:19757093 SB 203580 increases expression ISO RGD:1319634 6480464 SB 203580 results in increased expression of MAPK11 protein CTD PMID:19757093 SB 203580 decreases activity EXP 6480464 SB 203580 results in decreased activity of MAPK11 protein CTD PMID:24376630 SB 203580 multiple interactions ISO RGD:1319634 6480464 Cadmium Chloride inhibits the reaction [SB 203580 results in decreased expression of MAPK11 mRNA] more ... CTD PMID:19757093 , PMID:24465521 selenium atom increases expression ISO RGD:1319634 6480464 Selenium results in increased expression of MAPK11 mRNA CTD PMID:19244175 sodium arsenite multiple interactions ISO RGD:1319634 6480464 sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK11 protein CTD PMID:15504454 sunitinib decreases expression ISO RGD:1319634 6480464 Sunitinib results in decreased expression of MAPK11 mRNA CTD PMID:31533062 tamoxifen decreases expression ISO RGD:1319634 6480464 Tamoxifen results in decreased expression of MAPK11 mRNA CTD PMID:15590111 testosterone multiple interactions ISO RGD:1319634 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of MAPK11 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1319634 6480464 Testosterone results in increased expression of MAPK11 mRNA CTD PMID:21592394 titanium dioxide increases expression ISO RGD:1319635 6480464 titanium dioxide results in increased expression of MAPK11 mRNA CTD PMID:23557971 triclosan increases expression ISO RGD:1319634 6480464 Triclosan results in increased expression of MAPK11 mRNA CTD PMID:30510588 valproic acid increases expression ISO RGD:1319634 6480464 Valproic Acid results in increased expression of MAPK11 mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:1319634 6480464 Valproic Acid results in decreased methylation of MAPK11 gene CTD PMID:29501571 valproic acid increases methylation ISO RGD:1319634 6480464 Valproic Acid results in increased methylation of MAPK11 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1319634 6480464 Valproic Acid affects the expression of MAPK11 mRNA CTD PMID:25979313 vitamin E increases expression ISO RGD:1319634 6480464 Vitamin E results in increased expression of MAPK11 mRNA CTD PMID:19244175
Gene-Chemical Interaction Annotations
